Apollo Medical Holdings, Inc. announced following leadership transitions: Brandon Sim, the company's Co-CEO, has been named President and Chief Executive Officer, effective January 19, 2024 and Dr. Thomas Lam will serve as Vice Chairman of the Board of Directors and is retiring as President and Co-CEO, effective January 19, 2024. Dr. Lam, a co-founder of ApolloMed, led the Company in its growth from a private, regional organization in Southern California into a publicly traded, technology-powered integrated healthcare delivery platform empowering over 10,000 providers across the country. As part of a rigorously planned process, Mr. Sim will continue to lead ApolloMed into its next chapter of growth as President and CEO, alongside Mr. Basho, COO and CFO, and Dr. Kumar, CMO.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.75 USD | -1.63% | +5.59% | +9.01% |
May. 30 | Baird Starts Astrana Health With Outperform Rating, $54 Price Target | MT |
May. 16 | Transcript : Astrana Health, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.01% | 2.08B | |
+24.47% | 86.96B | |
-23.13% | 75.65B | |
+0.49% | 26.97B | |
+5.59% | 17.89B | |
-12.89% | 16.58B | |
+3.49% | 15.73B | |
+76.87% | 13.01B | |
+79.38% | 12.92B | |
+38.44% | 12.57B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Apollo Medical Holdings, Inc. Announces Executive Changes